Bolden Therapeutics

Developer of therapeutics to treat central nervous system diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2019 groups7 employees language boldentherapeutics.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace accelerating. Cited 8 times.

YearFilings
20231
20241
20251
20261

Social engagement

Social engagement: 898 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include NIH.

Investor typeCountShare
Venture capital233%
Other / undisclosed467%
Coming soon